EUVIMEDEUVIMED entdecken
Crossref

Extracellular DNA-associated inflammation in colorectal cancer metastasis: A testable TLR9-NF-κB-SPHK1/S1P framework and translational research agenda

Yu-Hui Shang, Shuang Han, Kai-Zhen Xu, Wen-Jian Hu, Jiu-Ning Huang, Yan-Dong Miao

World Journal of Translational Medicine · 13.11.2026

DOI: 10.5528/wjtm.124499 ↗

Kurz gefasst

Fachartikel in der Zeitschrift World Journal of Translational Medicine, online erschienen am 13.11.2026. Verfasst von Yu-Hui Shang und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colorectal cancer (CRC) metastasis, particularly liver metastasis, remains a major cause of treatment failure.Extracellular DNA (eDNA) released from neutrophil extracellular traps, damaged mitochondria, dying tumor cells, and microorganisms can accumulate in the tumor microenvironment, circulation, and liver pre-metastatic niche.This review evaluates whether eDNA sensing may connect chronic inflammation to metastatic progression through a proposed Toll-like receptor 9 (TLR9)-nuclear factor-κBsphingosine kinase 1/sphingosine-1-phosphate framework.TLR9 is considered a candidate endosomal sensor rather than an established initiating node; cyclic GMP-AMP synthase-stimulator of interferon genes and coiled-coil domain-containing protein 25 may cooperate with or substitute for TLR9 according to ligand localization, cellular compartment, and exposure context.Nuclear factor-κB and sphingosine kinase 1/sphingosine-1-phosphate could provide transcriptional and lipid-metabolic links to invasive plasticity, myeloid immunosuppression, vascular remodeling, and therapy resistance.However, no single CRC study has demonstrated the complete cascade from a defined eDNA ligand to metastatic outgrowth using cell-specific perturbation and rescue.The current evidence is further limited by heterogeneous ligand preparation, substantial extrapolation from non-CRC models, and a lack of prospective clinical validation.We therefore present this pathway as a falsifiable research framework and outline priorities for CRC-specific organoid, orthotopic, conditional-knockout, spatial multi-omic, and longitudinal clinical studies.A multidimensional eDNA-axis signature is discussed only as an illustrative future biomarker-development framework, not as a validated score for patient management.This synthesis may help define experiments and biomarker studies needed to determine when eDNA sensing is pro-metastatic, immunostimulatory, or therapeutically actionable in CRC.

Zitieren

APA

Shang, Y., Han, S., Xu, K., Hu, W., Huang, J., & Miao, Y. (2026). Extracellular DNA-associated inflammation in colorectal cancer metastasis: A testable TLR9-NF-κB-SPHK1/S1P framework and translational research agenda. World Journal of Translational Medicine. https://doi.org/10.5528/wjtm.124499

Vancouver

Shang Y, Han S, Xu K, Hu W, Huang J, Miao Y. Extracellular DNA-associated inflammation in colorectal cancer metastasis: A testable TLR9-NF-κB-SPHK1/S1P framework and translational research agenda. World Journal of Translational Medicine. 2026. doi:10.5528/wjtm.124499

BibTeX
@article{Shang2026,
  author = {Shang, Yu-Hui and Han, Shuang and Xu, Kai-Zhen and Hu, Wen-Jian and Huang, Jiu-Ning and Miao, Yan-Dong},
  title = {Extracellular DNA-associated inflammation in colorectal cancer metastasis: A testable TLR9-NF-κB-SPHK1/S1P framework and translational research agenda},
  journal = {World Journal of Translational Medicine},
  year = {2026},
  doi = {10.5528/wjtm.124499}
}
Kostenlos starten →